Thomas M Higgins

US Patent:

20090223411, Sep 10, 2009

Filed:

Mar 6, 2008

Appl. No.:

12/043874

Inventors:

Thomas L. Higgins - Lattingtown NY, US
Theodore Shlisky - Kings Park NY, US

International Classification:

C04B 41/50
B32B 13/12
B32B 27/02
C23C 16/00
B05D 1/02
B05D 1/28

US Classification:

1062871, 428451, 442164, 4272556, 4274211, 42742801, 427429

Abstract:

Methods of applications of organosilanes optionally having a nonhydrolyzable organic group, but having one or more hydrolyzable groups, with a polyol containing at least three hydroxy groups, where any two of the hydroxy groups are separated by at least three intervening atoms by aerosolization of droplets between 0.5-8 microns are disclosed and an improved formulation comprising adding a nonionic wetting agent are disclosed. An improved aerosolization application technique and the improved formulation provide for smaller droplet size and better coverage of substrates to which the organosilanes are applied. The improved formulation has increased affinity, reduces surface tension and therefore can covalently bond more quickly. A method of treating a substrate, and the treated substrate so formed, by contacting the substrate with the improved formulation for a period of time sufficient for treatment of the substrate are disclosed.

US Patent:

20100089408, Apr 15, 2010

Filed:

Feb 7, 2008

Appl. No.:

12/449464

Inventors:

Elizabeth McCaughey - New York NY, US
Thomas Higgins - Lattingtown NY, US
Theodore Shlisky - Kings Park NY, US

International Classification:

A61B 19/02
A61F 15/00

US Classification:

128846, 206440

Abstract:

This invention is directed to blood pressure cuff liners for reducing the possibility of infection to patients as a result of blood pressure measurements, and to methods of reducing such infections. The liners of the present invention provide a barrier between the patient and the blood pressure cuff used during blood pressure measurement, and also comprise chemical compounds that are able to eradicate most bacterial and viral pathogens, as well as fungi and molds. The liners of this invention are made to be disposable, but can be reused without risk to patients, because its pathogen-eradicating qualities protect patients from infection.

US Patent:

20100167613, Jul 1, 2010

Filed:

Mar 6, 2008

Appl. No.:

12/529883

Inventors:

Thomas L. Higgins - Lattingtown NY, US
Theodore Shlisky - Kings Park NY, US

International Classification:

C09D 5/14
B32B 5/02
B32B 9/00
B32B 5/16
B05D 1/02
B05D 1/28

US Classification:

442123, 106 1505, 428451, 428403, 428391, 4274211, 42742801, 427429

Abstract:

Methods of applications of organosilanes optionally having a nonhydrolyzable organic group, but having one or more hydrolyzable groups, with a polyol containing at least three hydroxy groups, where any two of the hydroxy groups are separated by at least three intervening atoms by aerosolization of droplets between 0.5-8 microns are disclosed and an improved formulation comprising adding a nonionic wetting agent are disclosed. An improved aerosolization application technique and the improved formulation provide for smaller droplet size and better coverage of substrates to which the organosilanes are applied. The improved formulation has increased affinity, reduces surface tension and therefore can covalently bond more quickly. A method of treating a substrate, and the treated substrate so formed, by contacting the substrate with the improved formulation for a period of time sufficient for treatment of the substrate are disclosed.

US Patent:

20170189318, Jul 6, 2017

Filed:

Oct 1, 2012

Appl. No.:

13/632910

Inventors:

Thomas L. Higgins - Lattingtown NY, US

International Classification:

A61K 8/898
A01N 33/12
A61Q 17/00
A61K 8/41
A61K 9/00

Abstract:

A method for treating human or animal skin, hands, feet, hair or nails to eliminate or reduce the number of microorganisms thereon by topical application of an aqueous formulation comprising antimicrobial organosilane quaternary ammonium compounds and benzalkonium chloride of the quaternary group, which provides antimicrobial and antiseptic activity. The method prevents reinfection for at least 12, preferably 24 and most preferably at least 60 hours. The formulation may further comprise methyl anthranilate, which performs the dual functions of fragrance (grape fragrance) and biocidal agent. The formulation may further comprise other compatible inert but desirable ingredients such as moisturizers, color and fragrance.